The company has been recognized for promoting an initiative to promote mild cognitive impairment ahead of time.
A. Menarini Singapore PTE. Limited (Malaysia) received the annual Marketing & Communication Program at the 2025 Healthcare Asia Pharma Awards, which praised the company's efforts to cope with mild cognitive impairment (MCI) through collaboration and education.
As the elderly population grows, mild cognitive impairment (MCI) becomes increasingly common, increasing the risk of dementia. However, managing MCI remains challenging due to low awareness, social stigma and limited medical resources. Many healthcare providers do not have the ability to fully identify or diagnose MCI, resulting in no opportunity for early intervention. Furthermore, the lack of structured guidelines and recommendation systems in primary care makes consistent management difficult
To address these challenges, A. Menarini Singapore PTE. Limited (Malaysia) has established an MCI steering committee that brings together experts to build an expert consensus on MCI management recognized by the Medical Association.
To support primary care providers, A. Menarini has partnered with the Malaysian Pharmaceutical Association (MPA) and the Malaysian Medical Association (MMA) to provide educational modules for general practitioners and pharmacists.
A key milestone was created with the University of Malaya to spin off Act4Health’s Visual Cognitive Assessment Test (VCAT) to enhance communication between patients and healthcare providers. In addition, the development of the MCI VCAT algorithm helps simplify patient evaluation and management, ensuring more efficient and structured care.
In a public advocacy program, A. Menarini, Caring Pharmacy and Act4Health offer free VCAT screening on select Caring Pharmacy media, encouraging early detection and intervention. These efforts greatly improve VCAT screening and establish EGB 761 as a recognized MCI treatment, improving patient care and advancing the healthcare industry.
Through ongoing education, awareness initiatives and practical tools, Singapore PTE. Limited (Malaysia) is changing the dialogue and making great strides in fighting the MCI.
The Healthcare Asian Pharmaceutical Awards appreciates Asian companies that redefine drug excellence. It offers recognition for game changers and visionaries with unwavering commitment to innovation and excellence.
Healthcare Asia Pharma Awards are presented by Healthcare Asia Magazine. To view the full list of winners, click here. If you want to join the 2026 awards ceremony and be recognized for the innovation and unique initiatives of the organization, thus enhancing your business and your pharma industry, please contact Julie Anne Nuñez. [email protected].
